| Vitrakvi 20 MG (as 24.6 MG larotrectinib sulfate) per 1 mL Oral Solution |
SY |
| VITRAKVI 20 MG in 1 mL Oral Solution |
PSN |
| VITRAKVI 20 MG in 1 mL Oral Solution |
PSN |
| Vitrakvi 20 MG per 1 mL Oral Solution |
SY |
| Vitrakvi 20 MG per 1 mL Oral Solution |
SY |
| Vitrakvi 20 MG/ML Oral Solution |
SY |
| Vitrakvi 20 MG/ML Oral Solution |
SY |
| Vitrakvi 25 MG (as 30.7 MG larotrectinib sulfate) Oral Capsule |
SY |
| Vitrakvi 25 MG (as 30.7 MG larotrectinib sulfate) Oral Capsule |
SY |
| Vitrakvi 25 MG Oral Capsule |
SY |
| Vitrakvi 25 MG Oral Capsule |
SY |
| VITRAKVI 25 MG Oral Capsule |
PSN |
| VITRAKVI 25 MG Oral Capsule |
PSN |
| Vitrase 200 UNT/ML in 1.2 ML Injection |
PSN |
| Vitrase 200 UNT/ML per 1.2 ML Injection |
SY |
| VIVA Drops 1 % Ophthalmic Solution |
PSN |
| Viva-Drops 1 % Lubricating Eye Drops |
SY |
| Viva-Drops Lubricating Eye Drops 10 MG/ML Ophthalmic Solution |
SY |
| Vivacaine (bupivacaine HCl 5 % / epinephrine (as epinephrine bitartrate) 1:200,000) in 1.8 mL Cartridge |
SY |
| Vivacaine 5 % / EPINEPHrine 1:200,000 in 1.8 ML Dental Cartridge |
PSN |
| Vivarin 200 MG Oral Tablet |
SY |
| Vivarin 200 MG Oral Tablet |
SY |
| VIVARIN 200 MG Oral Tablet |
PSN |
| VIVARIN 200 MG Oral Tablet |
PSN |
| Vivelle 0.025 MG/24HR Twice Weekly Transdermal Patch |
SY |
| Vivelle 0.025 MG/24HR Twice Weekly Transdermal Patch |
SY |
| Vivelle 0.1 MG/24HR Twice Weekly Transdermal Patch |
SY |
| Vivelle 0.1 MG/24HR Twice Weekly Transdermal Patch |
SY |
| Vivelle dot 0.025 MG/Day Twice Weekly Transdermal System |
PSN |
| Vivelle dot 0.025 MG/Day Twice Weekly Transdermal System |
SY |